The Institute would like to highlight the appointment of Anne-Marie Mes-Masson, to the prestigious Canada’s Most Powerful Women: Top 100 circle, in the Science and Technology category. One more reason to be proud? She was the Scientific Director of the Institute from 2003 to 2018!
A pioneer in the field of the creation of biobanks, her research over the past three decades has mainly focused on ovarian, breast and prostate cancers. She has established a translational research program focused on the development of personalized medicine in oncology and her fundamental research is focused on the prediction of therapeutic responses and on the development of new therapeutic agents for ovarian cancer and breast.
It is a fully deserved award for a researcher who shines through her excellence and her commitment to cancer research.
New treatment for prostate cancer approved
13 January 2023
An international study led by Dr. Fred Saad has resulted in the approval of a new treatment for metastatic castration-resistant […]
Preventing cells from aging: the discovery of Gerardo Ferbeyre and Sebastian Igelmann
17 January 2022
Gerardo Ferbeyre, a research member at the Institute, and Sebastian Igelmann, a doctoral student in his laboratory and first author […]